Table 1.
Asthmatic obese (AO) | Non-asthmatic obese (NAO) | Asthmatic non-obese (ANO) | Non-asthmatic non-obese (NANO) | P value | |
---|---|---|---|---|---|
N |
16 |
5 |
16 |
5 |
|
Age (years) |
10 |
11 |
9.5 |
28 |
0.6804 |
Sex (% males) |
56% |
40% |
62.5% |
40% |
0.7832 |
Total cholesterol |
176 |
214.2(a) |
136.75(a) |
111.8 |
0.0009 |
BMI |
28.16 ± 4.46 |
31.54 ± 4.12 |
18.79 ± 3.39 |
21.55 ± 1.63 |
0.0050 |
FVC |
102.5 |
102.8 |
94 |
90 |
0.3172 |
FEV1 |
91 |
102 |
86 |
98 |
0.2581 |
FEV1/FVC |
88 |
92.6 |
87.5 |
93 |
0.0752 |
HDL |
42.5 |
40.2 |
46.94 |
48 |
0.2919 |
VLDL |
15.5 |
24 |
17 |
14.4 |
0.2356 |
LDL |
82.0 |
146.6(b) |
90.38(b) |
71 |
0.0360 |
Tryglicerides |
77.0 |
120.8 |
76.88 |
83.6 |
0.1617 |
Glucose (g/dL) |
81.0 |
79 |
79.81 |
81.6 |
0.7901 |
IgE (U/mL) |
653.5(c) |
84.8 |
862.67(c) |
89.8 |
0.0007 |
Blood eosinophil (%) | 7.05(d) | 5.06 | 8.31(d) | 1.52 | 0.0024 |
Data presented as median or percentage (%) of subjects with the specified factor.
(a) and (b) p < 0.05 – versus to non-obese groups.
(c) and (d) p < 0.05 – versus to non-asthmatic groups.